BioSpace News Archive

Funding supports educational, community sustainability initiatives

Strategic expansion will meet increasing global demand for biopharmaceutical development and manufacturing.

In the midst of the greatest refugee crisis in world history, with 70 million people forcibly displaced from their homes due to violence and persecution, Bethany Global, a subsidiary of Bethany Christian Services, has formed a working agreement with the United Nations High Commission on Refugees to provide mental health and social services to Sudanese refugees in Gambella, Ethiopia.

Massachusetts General Hospital (MGH) and ideas42, a nonprofit behavioral design lab, today announced a new research collaboration aimed at supporting patients in emergency care seeking treatment for Opioid Use Disorder (OUD).

Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced the formation of a Scientific Advisory Board (SAB), consisting of several world-renowned immuno-oncology and drug development professionals.

Continuum Clinical’s Nariman Nasser, vice president of site engagement has been recognized by PharmaVOICE magazine as one of the “100 Most Inspiring People in the Life-Sciences Industry.”

The Xu Laboratory at the iHuman Institute of ShanghaiTech University has deciphered the high-resolution crystal structure of the first human Frizzled receptor.

The Centers for Medicare & Medicaid Services (CMS) has selected Maxim Healthcare Services as a Care Transformation Organization (CTO) for the Maryland Primary Care Program (MDPCP) beginning in January 2019.

Today, Nuevolution AB (publ) announced the identity of its “Cytokine X” program being a lead discovery program targeting inhibition of Interleukin IL-17A using small molecules.

“Heat and cold therapy is effective treatment for many ailments, especially for individuals with problems in their hands and fingers,” said an inventor from Henderson, Texas.